Aion Therapeutic Debt 2024

Aion Therapeutic Aktienanalyse

What does Aion Therapeutic do?

Aion Therapeutic Inc is a Canadian company specializing in the development of medications derived from cannabis and the research of these compounds. The company was founded in 2017 and has been operating on the Toronto Stock Exchange under the ticker symbol AION. The goal of Aion Therapeutic is to advance the development of innovative therapies based on the medical application of cannabinoids. The company focuses on discovering and testing medications that not only have high efficacy but also have a lower risk of side effects. Aion Therapeutic's business model is built on several pillars. This includes research and development of medications based on cannabis compounds such as CBD and THC. The company works closely with experts in the field of science and cannabinoid pharmaceutical production. Another important area is the distribution of cannabis products, such as seeds, oils, extracts, and dried flowers. The company utilizes innovative technologies and processes to improve the quality and effectiveness of these products. In terms of its business activities, Aion Therapeutic can be divided into different areas. One of the most important is the development of medications based on cannabis extract chemotypes that can be used for the prevention and treatment of diseases such as pain, inflammation, chronic conditions, and neurological disorders. The company collaborates closely with leading research institutes and universities worldwide to focus on developing methods that improve the effectiveness and safety of these products. Aion Therapeutic is also active in the manufacturing and marketing of cannabis products. The company offers high-quality cannabinoid extracts from different hemp varieties, specifically tailored to meet the needs of medical users. These products aim to enhance users' well-being and alleviate symptoms of chronic conditions. Another important area of Aion Therapeutic is the application of cannabis-based products in veterinary medicine. The company focuses on developing veterinary medicines specifically designed for pets such as dogs and cats. Similar to the medical application of CBD and THC in humans, the use in veterinary medicine aims to alleviate chronic pain and inflammation or enhance well-being. In summary, Aion Therapeutic is a company specializing in the development of cannabis-based medications and products. With a focus on new technologies and research findings, the company aims to improve the medical application of CBD and THC and establish them as a credible alternative to conventional medications. Aion Therapeutic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Aion Therapeutic's Debt Structure

Aion Therapeutic's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Aion Therapeutic's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Aion Therapeutic’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Aion Therapeutic’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Aion Therapeutic stock

What is the debt of Aion Therapeutic this year?

Aion Therapeutic has a debt level of 0.97 CAD this year.

What was the debt of Aion Therapeutic compared to the previous year?

The debt of Aion Therapeutic has increased by 31.08% compared to the previous year increased.

What are the consequences of high debt for investors in Aion Therapeutic?

High debt can pose a risk for investors of Aion Therapeutic, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Aion Therapeutic?

Low debt means that Aion Therapeutic has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Aion Therapeutic affect the company?

An increase in debt of Aion Therapeutic can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Aion Therapeutic affect the company?

A reduction in debt of Aion Therapeutic can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Aion Therapeutic?

Some factors that can influence the debt of Aion Therapeutic include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Aion Therapeutic so important for investors?

The debts of Aion Therapeutic are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Aion Therapeutic take to change the debt?

To change the debt, Aion Therapeutic can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Aion Therapeutic pay?

Over the past 12 months, Aion Therapeutic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aion Therapeutic is expected to pay a dividend of 0 CAD.

What is the dividend yield of Aion Therapeutic?

The current dividend yield of Aion Therapeutic is .

When does Aion Therapeutic pay dividends?

Aion Therapeutic pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aion Therapeutic?

Aion Therapeutic paid dividends every year for the past 0 years.

What is the dividend of Aion Therapeutic?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aion Therapeutic located?

Aion Therapeutic is assigned to the '-' sector.

Wann musste ich die Aktien von Aion Therapeutic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aion Therapeutic from 9/26/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.

When did Aion Therapeutic pay the last dividend?

The last dividend was paid out on 9/26/2024.

What was the dividend of Aion Therapeutic in the year 2023?

In the year 2023, Aion Therapeutic distributed 0 CAD as dividends.

In which currency does Aion Therapeutic pay out the dividend?

The dividends of Aion Therapeutic are distributed in CAD.